
About Aspiro Pharma Limited
Data last updated:
Aspiro Pharma Limited is a public limited company based in Markook, Telangana, India, a subsidiary of Hetero Labs Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2014PLC092771. Its GSTIN is 36AAMCA4474H1ZF (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1,470.1 Cr and a paid-up capital of ₹1,004.15 Cr. It is led by directors including Bandi Vamsikrishna and Reddy Narsimha.
Its last annual general meeting (AGM) was held on 24 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 321 Biotech Park, Markook, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹418.29 Cr, a growth of 147% compared to the previous year. For the same year it recorded a net profit of ₹25.39 Cr (net margin 6.1%) and EBITDA of ₹84.99 Cr (EBITDA margin 20.3%). Revenue has grown at a compounded annual rate (CAGR) of 67% over three years and 80% over five years.
The company has about 749 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Aspiro Pharma. As per MCA filings, the company has open charges of ₹206.91 Cr and satisfied charges of ₹46.89 Cr on record. Court records list 9 cases involving the company, including 2 filed by the company and 7 filed against it. The company has 8 deals on record (5 funding rounds, 3 secondary share transfers), with disclosed funding of ₹998.75 Cr; the latest was in October 2025. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations) are compared by revenue, 3 larger and 1 smaller; the largest is Milan Laboratories (India) Private Limited with revenue of ₹429.23 Cr. The company has 12 MSME Form 1 returns on record between 2016 and 2024, listing 198 overdue payments to 48 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aspiropharma.com.
Company details
CIN history
Aspiro Pharma has one previous CIN (Corporate Identification Number): U24100AP2014PLC092771. The current CIN is U24100TG2014PLC092771, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2014PLC092771 | Current |
| U24100AP2014PLC092771 | Previous |
Contact details
Aspiro Pharma Limited's registered office is in Markook, Telangana. Its website is aspiropharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 23 Survey No.321 Biotech Park Phase – III Karkapatla Villa, Ge, Markook, Telangana, India – 502281
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aspiro Pharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Aspiro Pharma operates one associated brand: Aspiro Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Research, development, and manufacturing of pharmaceutical formulations in India. | aspiropharma.com |
Business activity
The main business activity of Aspiro Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Aspiro Pharma Limited, buy the company report.
Financials of Aspiro Pharma Limited
FY 2025 filings availableAspiro Pharma Limited reported revenue of ₹418.29 Cr (up 147% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 80% over five years, including 147% growth in the latest year. EBITDA rose 316% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹418.29 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹84.99 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25.39 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.3% | ||||
| Net Profit Margin | 6.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aspiro Pharma Limited, buy the company report.
Board of directors of Aspiro Pharma Limited
Aspiro Pharma has 6 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bandi Vamsikrishna Also directs: Multiples Private Equity Fund II LLP, Allita Finvest and Advisors LLP, Eliana Investments and Holdings LLP and 5 more | Director | 13 Feb 2014 | 12 Years 9 Months | Current |
| Reddy Narsimha | Director | 03 Aug 2024 | 2 Years 3 Months | Current |
| Krishnaveni Kura Also directs: Editha Infraventures LLP, Jagger Infraventures LLP, Idhant Estate Properties LLP and 5 more | Director | 29 Jun 2017 | 9 Years 4 Months | Current |
| Ramaseshappa Siva Prasad Panchangam Also directs: Hetero Healthcare Limited, Lee Pharma Limited | Director | 03 Aug 2023 | 3 Years 3 Months | Current |
| Mahesh Ramappa Kamalamma Hassan Also directs: Annora Pharma Private Limited | Director | 07 Jun 2023 | 3 Years 5 Months | Current |
| Bhaskarreddy Pabbatireddy | Additional Director | 10 Oct 2025 | 1 Years 1 Months | Current |
Peer comparison
Aspiro Pharma Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Milan Laboratories (India) Private Limited | ₹429.23 Cr (FY 2024) | 42.0% | Thane, Maharashtra, India | |||
| Recipharm Pharmaservices Private Limited | ₹421.11 Cr (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| Albert David Ltd | ₹420.01 Cr (FY 2024) | 18.0% | Kolkata, West Bengal, India | |||
| Aspiro Pharma Limitedthis company | ₹418.29 Cr (FY 2025) | ₹25.39 Cr | 6.1% | 147.0% | 749 | Markook, Telangana, India |
| Themis Medicare Limited | ₹410.18 Cr (FY 2025) | 6.0% | Vapi, Gujarat, India |
To see the full peer comparison of Aspiro Pharma Limited, buy the company report.
Auditor
Aspiro Pharma Limited is audited by Suryanarayana Reddy and Co for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Suryanarayana Reddy and Co | FY 2025 | 005752S |
Shareholding
The shareholding of Aspiro Pharma Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aspiro Pharma Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2024 | 100989753 | Others | ₹100 Cr | Open | |
| 10 May 2024 | 100928366 | Others | ₹9 Lakh | Open | |
| 03 Apr 2024 | 100907989 | Others | ₹105 Cr | Open | |
| 04 Nov 2023 | 100824319 | Others | ₹13 Lakh | Open | |
| 26 Oct 2023 | 100809427 | Others | ₹10.24 Lakh | Open |
To see the full charge records of Aspiro Pharma Limited, buy the company report.
Total charge records: 16 View all charges
Deals & funding
Aspiro Pharma Limited has 8 deals on record (5 funding rounds, 3 secondary share transfers), with disclosed funding of ₹998.75 Cr; the latest was in October 2025.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2025 | Funding round | ₹600 Cr | Investors: Hetero Labs Limited |
| Oct 2024 | Secondary share transfer | Undisclosed | Buyer: Hetero Labs Limited Seller: an individual |
| Mar 2022 | Funding round | ₹150 Cr | Investors: Hetero Labs Limited |
| May 2018 | Funding round | ₹26.36 Cr | Investors: Hetero Labs Limited |
| Jun 2017 | Funding round | ₹82.91 Cr | Investors: Hetero Labs Limited |
To see the full deal history of Aspiro Pharma Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Aspiro Pharma Limited has 9 court cases on record: 2 filed by Aspiro Pharma, 7 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 4 | 0 |
| High courts | 3 | 3 | 0 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Writ petition | Filed against the company by an individual | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company | Disposed |
| High Court for State of Telangana | Court case (CRLP) | Filed against the company | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against an individual | Disposed |
To see the full case history of Aspiro Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Aspiro Pharma Limited has 12 MSME Form 1 returns on record between 2016 and 2024, listing 198 overdue payments to 48 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 48)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Yuno Packaging Private Limited | |||
| Nicomac Taikisha Clean Rooms Private Limited | |||
| Sri Sri Sai Ram Print Pack | |||
| Citrus Packaging Solutions Private Limited | |||
| S.R.Automations |
To see the full MSME payment records of Aspiro Pharma Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Aspiro Pharma has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Strivo Pharma Private Limited | U24302TG2016PTC109188 |
To see the full group structure of Aspiro Pharma Limited, buy the company report.
Employees & EPFO
Aspiro Pharma Limited has a workforce of 749 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 749 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2014-15 |
To see the full employee and EPFO history of Aspiro Pharma Limited, buy the company report.
GST
Aspiro Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAMCA4474H1ZF | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aspiro Pharma Limited, buy the company report.
Recent activity
Aspiro Pharma Limited has 21 board changes on record since 2014: 6 appointments and 15 cessations. The latest: Bhaskarreddy Pabbatireddy was appointed as Additional Director on 10 Oct 2025.
29 earlier events are in the company report.
Frequently asked questions
Aspiro Pharma is an active public limited company based in Markook, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 February 2014 (12+ years old) and is registered under CIN U24100TG2014PLC092771.
Aspiro Pharma has 6 current directors:
- Bandi Vamsikrishna - Director
- Reddy Narsimha - Director
- Krishnaveni Kura - Director
- Ramaseshappa Siva Prasad Panchangam - Director
- Mahesh Ramappa Kamalamma Hassan - Director
- Bhaskarreddy Pabbatireddy - Additional Director
The latest financial statements of Aspiro Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aspiro Pharma is 36AAMCA4474H1ZF, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Aspiro Pharma is U24100TG2014PLC092771. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aspiro Pharma has 9 court cases on record: 2 filed by the company and 7 filed against it. Most are in the district courts.
Aspiro Pharma was incorporated on 05 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Aspiro Pharma has 8 deals on record (5 funding rounds, 3 secondary share transfers), with disclosed funding of ₹998.75 Cr; the latest was in October 2025.
The peers of Aspiro Pharma by revenue are Milan Laboratories (India) Private Limited, Recipharm Pharmaservices Private Limited, Albert David Ltd, Themis Medicare Limited, all in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Bhaskarreddy Pabbatireddy was appointed as Additional Director on 10 Oct 2025. Reddy Narsimha ceased to be Additional Director on 18 Aug 2024. Reddy Narsimha was appointed as Director on 03 Aug 2024. Aspiro Pharma has 21 board changes on record in total.
Aspiro Pharma has 12 MSME Form 1 returns on record between 2016 and 2024, listing 198 overdue payments to 48 micro and small suppliers. The latest return was filed on 25 Apr 2024.
Aspiro Pharma can be reached through the website aspiropharma.com. Its registered office is in Markook, Telangana, India.

